India to Peru: Cephalexin Export Trade Route

The India to Peru Cephalexin corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $2.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's cephalexin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $74.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with cephalexin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 15.2%, placing it at rank #11 among India's top cephalexin export destinations globally.

On the import side, key buyers of Indian cephalexin in Peru include SUN PHARMACEUTICAL INDUSTRIES SAC, CAFERMA S.A.C., NA and 13 others. SUN PHARMACEUTICAL INDUSTRIES SAC is the single largest importer with 2 shipments valued at $1.6M USD.

India's cephalexin exports to Peru are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, BRAWN LABORATORIES LIMITED, KURAME LLP — together account for 89% of total trade value on this route. The average shipment value of $74.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cephalexin capsules 500mg (each capsulecontaining cephalexin equivalent to 500mg of anhydrous cephalexinnos and cephalexin capsules 500mg (each capsule , suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUN PHARMACEUTICAL INDUSTRIES SAC is the largest importer with 2 shipments worth $1.6M USD — representing 71% of all cephalexin imports from India on this route. A total of 16 buyers are active on this corridor.